BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23278525)

  • 1. Assessment of protein expression and gene status of human epidermal growth factor receptor (HER) family molecules in ameloblastomas.
    Oikawa M; Miki Y; Shimizu Y; Kumamoto H
    J Oral Pathol Med; 2013 May; 42(5):424-34. PubMed ID: 23278525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
    Kumamoto H; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
    Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
    Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
    Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
    Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
    J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.
    Steffensen KD; Waldstrøm M; Andersen RF; Olsen DA; Jeppesen U; Knudsen HJ; Brandslund I; Jakobsen A
    Int J Oncol; 2008 Jul; 33(1):195-204. PubMed ID: 18575766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients.
    Sassen A; Rochon J; Wild P; Hartmann A; Hofstaedter F; Schwarz S; Brockhoff G
    Breast Cancer Res; 2008; 10(1):R2. PubMed ID: 18182100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological evaluation of 164 dental follicles and dentigerous cysts with emphasis on the presence of odontogenic epithelium in the connective tissue. The hypothesis of "focal ameloblastoma".
    Meleti M; van der Waal I
    Med Oral Patol Oral Cir Bucal; 2013 Jan; 18(1):e60-4. PubMed ID: 23085710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
    J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of HER2 protein in breast cancer is biologically significant.
    Tovey SM; Reeves JR; Stanton P; Ozanne BW; Bartlett JM; Cooke TG
    J Pathol; 2006 Nov; 210(3):358-62. PubMed ID: 16981252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical assessment of ATG7, LC3, and p62 in ameloblastomas.
    Okada M; Oikawa M; Miki Y; Shimizu Y; Echigo S; Takahashi T; Kumamoto H
    J Oral Pathol Med; 2014 Sep; 43(8):606-12. PubMed ID: 24762217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma.
    Nishijima T; Yamamoto H; Nakano T; Nakashima T; Taguchi K; Masuda M; Motoshita J; Komune S; Oda Y
    Hum Pathol; 2015 Nov; 46(11):1730-43. PubMed ID: 26345124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
    da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 Oct; 34(9):565-72. PubMed ID: 16138896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer.
    Witton CJ; Reeves JR; Going JJ; Cooke TG; Bartlett JM
    J Pathol; 2003 Jul; 200(3):290-7. PubMed ID: 12845624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical investigation of epidermal growth factor receptor expression in ameloblastomas.
    Ueno S; Miyagawa T; Kaji R; Mushimoto K; Shirasu R
    J Pathol; 1994 May; 173(1):33-8. PubMed ID: 7931835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.